Pharvaris NV
F:9EN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharvaris NV
F:9EN
|
NL |
|
F
|
Fresenius SE & Co KGaA
XBER:FRE
|
DE |
|
S
|
Somboon Advance Technology PCL
SET:SAT
|
TH |
|
H
|
Henkel AG & Co KGaA
SWB:HEN
|
DE |
|
H
|
HSBC Holdings PLC
XMUN:HBC1
|
UK |
|
T
|
Tenaris SA
OTC:TNRSF
|
LU |
|
N
|
National Grid PLC
SWB:NNGF
|
UK |
|
O
|
Onto Innovation Inc
XMUN:NNM
|
US |
|
D
|
Darden Restaurants Inc
XMUN:DDN
|
US |
|
C
|
Celestica Inc
XMUN:CTW0
|
CA |
|
M
|
Mitsubishi Heavy Industries Ltd
OTC:MHVYF
|
JP |
|
Saul Centers Inc
NYSE:BFS
|
US |
|
W
|
Workday Inc
XMUN:W7D
|
US |
|
N
|
Nokia Oyj
PSE:NOKIA
|
FI |
|
A
|
ASM International NV
F:AVS
|
NL |
|
H
|
HomeServe PLC
F:XHSB
|
UK |
|
S
|
Siam Global House PCL
SET:GLOBAL
|
TH |
|
C
|
Coca-Cola Co
F:CCC3
|
US |
|
Z
|
Z Holdings Corp
XBER:YOJ
|
JP |
|
Tsingtao Brewery Co Ltd
F:TSI
|
CN |
|
S
|
Suzuki Motor Corp
DUS:SUK
|
JP |
|
Banco Santander SA
F:BSD2
|
ES |
Bankruptcy Probability
Pharvaris NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Pharvaris NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NL |
|
Pharvaris NV
NASDAQ:PHVS
|
2.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
625.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
322.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
239.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
183.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
252.2B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Pharvaris NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Pharvaris NV has total debt of 532.6k EUR. This includes both short-term (0 EUR) and long-term (532.6k EUR) debt.
You can find a full breakdown on its Balance Sheet.
